PDC*line Pharma Investors
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.
.png)
Headquarters:
La Tronche, Rhone-Alpes, France
Industry:
Advanced and Next Generation Therapies (Various)
Investor Type:
Pharma Company
Technology:
Advanced Longevity (R&D)
Employee Number:
1-10
Founded Date:
2014